Gila Diagnostics, Inc.
Developer of a proteomics-focused platform for multiplexed immunoassays intended to support precision medicine, biomarker discovery, and quantitative assessment of immune responses. Describes a sequencing-linked, high-throughput in-solution protein array approach and offers project support for assay implementation.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Multiplexed in-solution protein array platform
A sequencing-linked in-solution protein array platform designed to screen hundreds of targets across large sample sets with quantitative outputs and an expanded dynamic range.
Multiplexed in-solution protein array platform
A sequencing-linked in-solution protein array platform designed to screen hundreds of targets across large sample sets with quantitative outputs and an expanded dynamic range.
Services
Project-based services to run multiplexed, sequencing-linked protein assays, including assay execution and assistance organizing processes and results.
Project-based services to run multiplexed, sequencing-linked protein assays, including assay execution and assistance organizing processes and results.
Expertise Areas
- Proteomics platform development
- Multiplex immunoassays
- Biomarker discovery and validation
- High-throughput screening
Key Technologies
- Next-generation sequencing-based readout
- In-solution multiplex protein arrays
- Programmable protein arrays
- High-throughput sample processing
News & Updates
Publication (PDF) hosted on the site concerning quantitative assessment of multiple pathogen exposures.
Publication (PDF) hosted on the site concerning quantitative assessment of multiple pathogen exposures.